Symptoms such as abdominal pain, jaundice
(yellowing of the skin and eyes), unexplained weight loss, and alterations in
bowel habits can lead to the utilization of the CA 19-9 serum test. This
medical test is commonly employed to evaluate and monitor pancreatic cancer.
Elevated CA 19-9 levels in the blood may suggest the presence of pancreatic
cancer, although it can also be raised in other conditions like pancreatitis,
gallbladder disease, or liver disease. The CA 19-9 test serves as a valuable
tool for healthcare providers in assessing the potential presence of pancreatic
cancer and monitoring treatment responses for this condition.